Efficacy and Safety of Very-Low-Dose Cangrelor Following Acute Neuroendovascular Intervention (SCCM 2026) - Mar 17, 2026 - Pres time: Mar 24, 2026; 11:15 AM - 12:15 PM; Location: Connections Central - RST 09; "Very low dose cangrelor may be effective in preventing thrombotic complications with a low rate of symptomatic bleeding events in patients undergoing neuroendovascular procedures. The incorporation of platelet function testing may optimize antiplatelet selection and dosing after a neuroendovascular procedure."
Clinical • Cardiovascular • Ischemic stroke • Thrombosis
|
|
Joshua McBride, PharmD, BCCCP (he/him/his); Fawad Shaheen, MD; Samantha Westervelt, MSN, APRN, FNP-C; Desiree Kennedy, MSN, APRN, FNP-C
|